Innovations in personalised diabetes care and risk management. (December 2019)

• Record Type: Journal Article
• Authors: Nijpels, Giel; Beulens, Joline WJ; van der Heijden, Amber AWA; Elders, Petra J
• Other Names: Aboyans Victor guest-editor.; Cosentino Francesco guest-editor.
• Is Part Of: European journal of preventive cardiology. Volume 26(2019)Supplement 2
• Page Start: 125
• Page End: 132
• Publication Date: 2019-12
• Subjects: Complications -- diabetes -- personalised medicine -- risk stratification; Cardiovascular system -- Diseases -- Prevention -- Periodicals; Cardiac patients -- Rehabilitation -- Periodicals; 616.12
• DOI: 10.1177/2047487319880043
• Languages: English
• ISSNs: 2047-4873

Abstract

Type 2 diabetes is associated with an increased risk of developing macro and microvascular complications. Nevertheless, there is substantial heterogeneity between people with type 2 diabetes in their risk of developing such complications. Personalised medicine for people with type 2 diabetes may aid in efficient and tailored diabetes care for those at increased risk of developing such complications. Recently, progress has been made in the development of personalised diabetes care in several areas. Particularly for the risk prediction of cardiovascular disease, retinopathy and nephropathy, innovative methods have been developed for prediction and tailored monitoring or treatment to prevent such complications. For other complications or subpopulations of people with type 2 diabetes, such as the frail elderly, efforts are currently ongoing to develop such methods. In this review, we discuss the recent developments in innovations of personalised diabetes care for different complications and subpopulations of people with type 2 diabetes, their performance and modes of application in clinical practice.